Dr Reddys Laboratories (RDY) Enterprise Value Growth (5y) (2014 - 2026)
Dr Reddys Laboratories (RDY) Enterprise Value Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48% |
| Mar 31, 2025 | 12.09% |
| Mar 31, 2024 | -18.65% |
| Jun 30, 2023 | -25.30% |
| Mar 31, 2023 | -28.83% |
| Jun 30, 2022 | -16.74% |
| Mar 31, 2022 | -22.59% |
| Dec 31, 2020 | 29.69% |
| Sep 30, 2020 | -16.21% |
| Mar 31, 2020 | -52.75% |
| Dec 31, 2019 | 95.85% |
| Sep 30, 2019 | 15.25% |
| Dec 31, 2018 | 20.17% |
| Jun 30, 2018 | -47.80% |
| Mar 31, 2018 | 10.02% |
| Dec 31, 2017 | -660.08% |
| Sep 30, 2017 | -613.14% |
| Jun 17, 2017 | -43.92% |
| Mar 17, 2017 | 24.64% |
| Dec 31, 2016 | -570.53% |